EuroPCR 2023: Improving outcomes in mitral regurgitation
Francesco Maisano, Marianna Adamo, Alison Duncan, Georg Nickenig and Greg Stone discuss the role of COAPT trial evidence in reducing mitral regurgitation and securing optimal outcomes for patients. Points also discussed include patient selection, repair or replacement, and real-world registry evidence on reducing MR with TEER.
Related Videos
EuroPCR 2023: COAPT 5-year follow-up
EuroPCR 2023: Tricuspid valve
EuroPCR 2023: Defining the future
EuroPCR 2023: Vascular access
Narcisa's testimonial
AV VALVES 2023:HF and VHD – Patient Management
Anatomical overview of the AV Valves
TAVI 2023: Optimizing TAVI
Navitor™: Voice of the Experts Francesco Nicolas Dumonteil
CardioMems™
TAVI Summit - Cardiac imaging and morphology